LifeNet Health

Give your treatment and patient goals every advantage. Nexeon® enables graft access as early as two weeks after implantation—at least 6X faster than an arteriovenous fistula.¹ ²* 1. Data on file LifeNet Health® ES-19-076. 2. Bylsma, L. C., Gage, S. M., Reichert, H., Dahl, S. L. M., & Lawson, J. H. (2017). Arteriovenous fistulae for haemodialysis: a systematic review and meta-analysis of efficacy and safety outcomes. European journal of vascular and endovascular surgery, 54(4), 513-522. https://lnkd.in/gpGDy637 * Based on a preclinical in vivo animal study. ¹ Results in animals may not be representative of results in humans.

Patients want to return to what matters. Support their view of success with world's first decellularized, sterile, room temperature vascular allograft.

We are live from #VEITHSymposium — you can’t miss us! We’re right at the top of the escalator, booth #601, showcasing Nexeon® Advanced Vascular Allograft. See how this room temperature, decellularized femoral artery is redefining vascular access, bypass, and reconstruction. #VEITH2025 #VascularSurgery #Hemodialysis #AVAccess #LifeNetHealth #Nexeon https://hubs.ly/Q03TSMPZ0

Pick a solution that supports you & your patient’s goals. ViviGen® Cellular Bone Matrix offers cells, signals, & scaffold, ready in 5 minutes or less.¹ 1. Venuti, N., & Mohan, V.P. Spinal Fusion with Mesenchymal Stem Cell Bone Matrices: A Review on Product Comparison. Spine Res. 2019, 5, 1–9. Pg No: 5

Patients see surgery as a way forward. PliaFX® Advanced Fiber DBMs support that, containing endogenous growth factors that are vital for bone formation.¹ ⁺ ¹ McLean et al, ‘Cell Attachment and Osteoinductive Properties of Tissue Engineered, Demineralized Bone Fibers for Bone Void Filling Applications’, Clinical Implementation of Bone Regeneration and Maintenance. IntechOpen, Feb. 10, 2021. doi: 10.5772/intechopen.88290. Pg No: 9, 10 and 11. ⁺ Pre-clinical test data/results may not necessarily be indicative of human clinical performance (or outcomes).